跳转至内容
Merck
CN
所有图片(1)

主要文件

Y0001297

Iopentol

European Pharmacopoeia (EP) Reference Standard

别名:

5-[Acetyl(2-hydroxy-3-methylpropyl)amino]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C20H28I3N3O9
CAS号:
分子量:
835.16
UNSPSC代码:
41116107
NACRES:
NA.24

等级

pharmaceutical primary standard

API类

iopentol

制造商/商品名称

EDQM

应用

pharmaceutical (small molecule)

包装形式

neat

储存温度

2-8°C

SMILES字符串

Ic1c(c(c(c(c1C(=O)NCC(O)CO)I)C(=O)NCC(O)CO)I)N(CC(O)COC)C(=O)C

InChI

1S/C20H28I3N3O9/c1-9(29)26(5-12(32)8-35-2)18-16(22)13(19(33)24-3-10(30)6-27)15(21)14(17(18)23)20(34)25-4-11(31)7-28/h10-12,27-28,30-32H,3-8H2,1-2H3,(H,24,33)(H,25,34)

InChI key

IUNJANQVIJDFTQ-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Iopentol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

K Katsanos et al.
Clinical hemorheology and microcirculation, 39(1-4), 87-91 (2008-05-27)
Iodinated contrast media (CM) are widely used in diagnostic imaging and therapeutic interventional procedures of everyday clinical practice and are associated with multiple hemodynamic and hemorheological effects. The purpose of our work was to investigate the red blood cell (RBC)
P Dewachter et al.
Journal de radiologie, 82(9 Pt 1), 973-977 (2001-10-10)
The etiology of severe reactions following injection of iodinated contrast agents is the subject of controversy. No consensus has been established regarding the management of patients at risk, risk factors and premedication because in most cases published no diagnostic exploration
Steffen Ross et al.
AJR. American journal of roentgenology, 190(5), 1380-1389 (2008-04-24)
The objective of our study was to establish a standardized procedure for postmortem whole-body CT-based angiography with lipophilic and hydrophilic contrast media solutions and to compare the results of these two methods. Minimally invasive postmortem CT angiography was performed on
J E Roos et al.
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 176(4), 556-563 (2004-04-17)
To evaluate the impact of different iodine concentrations of intravenous contrast agent on hepatic and vascular enhancement during arterial and porto-venous phase imaging using a 4-channel multi-detector row CT (MDCT). One hundred consecutive patients referred for triphasic abdominal MDCT were
Volkmar Lufft et al.
European radiology, 12(4), 804-809 (2002-04-18)
The aim of this study was to compare renal function between patients with renal angiography and patients with renal angiography and angioplasty (AP) for renal artery stenosis (RAS). Forty-seven patients with suspected RAS were prospectively investigated by digital subtraction angiography

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门